ABSTRACT
The results of this randomized multicenter trial are in contrast to those of a single-center randomized trial of 200 patients with in-stent restenosis, randomized to either dilatation or rotational atherectomy.12 Preliminary data in this trial document no difference in 30-day major adverse cardiac events, but less target lesion reintervention for rotational atherectomy, although procedural performance in both limbs was different, with more new stents placed in the dilatation limb which could have had impacted the results. At the present time, rotational atherectomy has not been proven to reduce recurrent restenosis in the setting of in-stent restenosis.
